Muscular Dystrophy Canada is providing $366,000 to Alberta Precision Laboratories to begin screening newborns for spinal muscular atrophy (SMA). SMA is a rare genetic condition that causes muscle weakness. The test, which is part of a Read More
Muscular Dystrophy Canada is providing $366,000 to Alberta Precision Laboratories to begin screening newborns for spinal muscular atrophy (SMA). SMA is a rare genetic condition that causes muscle weakness. The test, which is part of a Read More